Physician profile
Lance H Edwards
NPI 1487638037
$1,690.41
in general payments reported to CMS, 2019-2025
17 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $41.76 · 2021: $191 · 2022: $131 · 2023: $243 · 2024: $392 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.78 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $632.58 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $197.65 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $189.10 | 2022-2025 | |
| Daiichi Sankyo INC. | $128.76 | 2023-2025 | Injectafer |
| Lupin INC. | $119.67 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.10 | 2020-2025 | |
| Coopersurgical, INC. | $54.15 | 2021-2024 | Paragard T 380a |
| Astellas Pharma US INC | $42.10 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $38.50 | 2021 | |
| Idorsia Pharmaceuticals US INC | $35.00 | 2023 | Quviviq |
| Thd America, INC. | $28.42 | 2025 | |
| Millicent US INC | $26.70 | 2024 | |
| Organon LLC | $26.28 | 2022-2023 | Nexplanon |
| Pfizer INC. | $23.70 | 2025 | |
| Shield Therapeutics INC | $23.23 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $15.48 | 2019 | |
| Allergan, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.